Verteporfin Photodynamic Therapy

DRUG5 trials

Sponsors

Novartis Pharmaceuticals, Asociación para Evitar la Ceguera en México, Novartis

Conditions

Age Related Macular DegenerationChoroidal NeovascularizationMacular DegenerationPolypoidal Choroidal Vasculopathy

Phase 2

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

TerminatedNCT00347399

Asociación para Evitar la Ceguera en MéxicoAge Related Macular Degeneration

Start: 2006-03-31End: 2007-06-30Updated: 2024-05-30

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

TerminatedNCT00433017

NovartisChoroidal Neovascularization, Macular Degeneration

Start: 2007-05-31End: 2009-07-31Updated: 2011-04-21

Phase 3

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib

CompletedNCT00242580

Novartis PharmaceuticalsChoroidal Neovascularization, Macular Degeneration

Start: 2005-09-30Updated: 2016-03-31

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

CompletedNCT00436553

NovartisChoroidal Neovascularization, Macular Degeneration

Start: 2007-02-28End: 2009-10-31Updated: 2011-04-19

Phase 4

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

CompletedNCT00674323

NovartisPolypoidal Choroidal Vasculopathy

Start: 2008-04-30Updated: 2011-04-19

Related Papers

EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy

British Journal of Ophthalmology2015-03-10143 citations

Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy

British Journal of Ophthalmology2014-07-3087 citations